Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
- Citation:
- Prostate Cancer Prostatic Dis
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- Parents:
- 3474
- Children:
- None
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233180, UG1CA233253, UG1CA233341, United States Army Medical Research W81XWH-18-1-0278
- Corr. Author:
- Authors:
- Andrew B. Nixon Yingmiao Liu Qian Yang Bin Luo Mark D. Starr John C. Brady Wm. Kevin Kelly Himisha Beltran Michael J. Morris Daniel J. George Andrew J. Armstrong Susan Halabi
- Networks:
- LAPS-MA036, LAPS-NC010, LAPS-NY016
- Study
- CALGB-90401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: